| 000 | 01768 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516175457.0 | ||
| 264 | 0 | _c20140331 | |
| 008 | 201403s 0 0 eng d | ||
| 022 | _a1539-3704 | ||
| 024 | 7 |
_a10.7326/0003-4819-160-1-201401070-00731 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiller, Laura | |
| 245 | 0 | 0 |
_aElevated risk for invasive meningococcal disease among persons with HIV. _h[electronic resource] |
| 260 |
_bAnnals of internal medicine _cJan 2014 |
||
| 300 |
_a30-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xcomplications |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aCD4 Lymphocyte Count |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMeningococcal Infections _xcomplications |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNew York City _xepidemiology |
| 650 | 0 | 4 | _aPopulation Surveillance |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aViral Load |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aArakaki, Lola | |
| 700 | 1 | _aRamautar, Arianne | |
| 700 | 1 | _aBodach, Sara | |
| 700 | 1 | _aBraunstein, Sarah L | |
| 700 | 1 | _aKennedy, Joseph | |
| 700 | 1 | _aSteiner-Sichel, Linda | |
| 700 | 1 | _aNgai, Stephanie | |
| 700 | 1 | _aShepard, Colin | |
| 700 | 1 | _aWeiss, Don | |
| 773 | 0 |
_tAnnals of internal medicine _gvol. 160 _gno. 1 _gp. 30-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7326/0003-4819-160-1-201401070-00731 _zAvailable from publisher's website |
| 999 |
_c23208351 _d23208351 |
||